• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RGT

ARGENT BIOPHARMA LIMITED - Charts / Financials

14.1% ! 8.9¢
Market Cap $6.424M  !
Healthcare Drug Manufacturers - Major
Add to My Watchlist

Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug... Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.More

refresh Created with Sketch. REFRESH
Last update - 11.55am 29/07/2025 (20 minute delay) ?
Day
Open 8.1¢   Day High 8.9¢   Day Low 8.0¢
Daily Volume 90000
Bids   Sellers
Number Price Volume   Number Price Volume
1 7.8¢ 12820   1 8.5¢ 140

Directors & Senior Management

Mr. Roby Reuven Zomer Chief Executive Officer, Managing Director, Executive Director
Ms. Yifat Steuer Deputy Chief Executive Officer, Chief Operating Officer
Mr. Igor Bluvstein Chief Financial Officer
Mr. Robert Clements Chief Commercial Officer
Mr. Rowan Harland Company Secretary
Mr. Gary Hermon Non-Executive Director
Mr. Daniel Robinson Non-Executive Director

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.9¢ 		Change
0.011(14.1%) 		Mkt cap ! $6.424M
Open High Low Value Volume
8.1¢ 8.9¢ 8.0¢ $7.466K 90K

Buyers (Bids)

No. Vol. Price($)
1 12820 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.5¢ 140 1
View Market Depth
Last trade - 11.52am 29/07/2025 (20 minute delay) ?

Top Stories

Wildcat’s PFS elicits lacklustre response

Wildcat has issued a PFS for its Tabba Tabba project, but the market hasn’t liked it @ shares were down -8.3% at lunchtime. Some HotCopper users were concerned Wildcat has relied on assumed lithium prices well above what other majors like Pilbara Minerals (ASX:PLS) are currently s...
Emyria Advances kicks off National Rollout with Avive Health Agreement Clinical-stage biotech and mental health innovator Emyria Limited (ASX:EMD) has fired up its national expansion strategy by signing a landmark agreement with Avive Health, a growing private hospital operator, to establish its first Empax clinic in Queensland.Under the agreement, Emyria will integ...
HotCopper Trends: Vection's $7M, Liontown dips & Wildcat PFS Let’s check in on what’s trending on the HotCopper forums on Tuesday. The following companies are catching eyes in the intraday session: Vection Technologies (ASX:VR1) @ Vection has received a contract extension from an undisclosed EU-based client worth just ove...
One of the biggest jumps today is the most obscure: Beonic Ltd up +65% The HotCopper forums collectively missed one of the day’s top gainers, as far as the list of most popular companies according to users goes. Beonic Ltd (ASX:BEO), an aviation-facing tech stock, has inked a deal to provide LIDAR-based passenger foot traffic data to seven airports i...
DUG Technology taking Shell to US District Court over A$4.75M dispute DUG Technology (ASX:DUG) shares sunk -5.5% late morning Tuesday as the company revealed it’s taking a subsidiary of global oil giant Shell to the US District Court. The dispute, valued at US$3.1M (A$4.75M), is a long-running matter that originated in the early 2020&CloseCurlyQuote...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.